4.7 Article

Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease

Journal

Publisher

AMER THORACIC SOC
DOI: 10.1164/rccm.201912-2384PP

Keywords

-

Funding

  1. COPD Biomarker Qualification Consortium
  2. AstraZeneca
  3. Boehringer Ingelheim
  4. GlaxoSmithKline
  5. Chiesi
  6. National Institute for Health Research Manchester Biomedical Research Centre

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available